News Conference News ESC 2021 PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer Michael O'Riordan August 30, 2021
News Conference News ESC 2021 New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT Shelley Wood August 28, 2021
News Daily News Milrinone, Dobutamine Comparable for Cardiogenic Shock: DOREMI Todd Neale August 10, 2021
News Daily News Getting More Women in CV Research Will ‘Take a Village’ Yael L. Maxwell August 09, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2021 Shelley Wood August 02, 2021
News Conference News SCCT 2021 COVID-19’s Effects on Cardiac Imaging Protocols, Perspectives Still Unfolding Yael L. Maxwell July 23, 2021
News Conference News TVT 2021 TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year Todd Neale July 20, 2021
News Daily News Complete Revascularization Best for Most ACS Patients With MVD Michael O'Riordan June 25, 2021
News Daily News Tobacco Use Still Rampant Among CVD Patients Who Know Better Yael L. Maxwell June 09, 2021
News Conference News ACC 2021 Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics L.A. McKeown May 24, 2021
News Conference News ACC 2021 Use of a Rapid, High-Sensitivity Troponin Protocol Doesn’t Boost 1-Year Outcomes Todd Neale May 16, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2021 Caitlin E. Cox May 03, 2021
News Daily News AHA/ASA Offers Advice on Rare Blood Clots Seen After Vaccines for COVID-19 Todd Neale April 30, 2021
News Conference News SCAI 2021 Cardiogenic Shock: Protocols, Clear Definitions Advance the Field Caitlin E. Cox April 30, 2021
News Daily News Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement Yael L. Maxwell April 26, 2021